|Articles|November 1, 2003

Pancreatic Aid

V.E.T. Pharmaceuticals offers Epizyme?, an affordable product for use in animals with deficient pancreatic secretions, the company says.

V.E.T. Pharmaceuticals offers Epizyme, an affordable product for use in animals with deficient pancreatic secretions, the company says. Epizyme works to restore the proper digestion of carbohydrates, fats and proteins to aid in relieving the signs of chronic pancreatic insufficiency. The product is packaged in 4-ounce, 8-ounce and 12-ounce powders.

For fastest response call (866) 838-1995 or visit the Web site at www.vet-pharmaceuticals.com.

From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.

Related to this article

September 19th, 2026

Why pet owners decline vaccines: Survey insights and strategies for navigating hesitancy

In a keynote address at the 2026 Fetch National Harbor Veterinary Conference, Jessica Pritchard, VMD, MS, DACVIM (SAIM), shared research showing that many owners decline vaccines because they do not think their pet needs them, and discussed ways veterinary teams can address those concerns.

September 19th, 2026

Veterinary triage for technicians: Assessing urgency, communicating with clients, and coordinating the team

Alyssa Mages, BS, CVT, FVTE, outlines key considerations for veterinary technicians during triage, from rapid patient assessment and prioritization to client communication and team coordination, in this interview from the Fetch National Harbor Veterinary Conference.

September 18th, 2026

Good flea control is good tapeworm control, veterinarian tells Fetch attendees

In a session at the 2026 Fetch National Harbor conference, Nathanael Oster, VMD, MBA, walked attendees through the biology, diagnosis, and treatment of the flea tapeworm in dogs and cats, including why cats are affected more often than dogs.

September 18th, 2026

SNAP-P: If rotisserie chicken, why not pet food?

SNAP-P is a proposed high-impact program that would provide at least $4.4 billion in benefits to low-income pet owners at marginal cost to federal and state governments.

September 18th, 2026

Inside veterinary social work

In a slideshow drawn from an onsite dvm360 interview at Fetch National Harbor, a veterinary oncologist and a veterinary social worker walk through how the role supports owners and staff across a pet's cancer diagnosis, treatment, and end-of-life care.

September 18th, 2026

Wrap up: New World screwworm confirmed in a US horse, and other news

Here are this week's headlines

September 17th, 2026

Dave & Cheryl Duffield Foundation commits $250 million to expand veterinary care access

The five-year Big Bet for Pets initiative targets what the foundation calls a care gap affecting 50 million dogs and cats in the US, opening two new grant programs for nonprofit veterinary clinics.

September 17th, 2026

New study takes aim at copper-associated liver disease in Labrador retrievers

A UC Davis study is investigating why Labrador retrievers develop copper-associated hepatopathy and whether blood-based tools could help identify the disease before serious liver damage occurs.

Pancreatic Aid

Related to this article

Trending on dvm360

New study takes aim at copper-associated liver disease in Labrador retrievers

Why pet owners decline vaccines: Survey insights and strategies for navigating hesitancy

Approaching parrot behavior cases: From behavioral history to treatment

Veterinary triage for technicians: Assessing urgency, communicating with clients, and coordinating the team

Q&A: The truth about Toxoplasma gondii risk from household cats